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ABSTRACT
Objectives: The exact pathogenesis of neural tube defects (NTDs) is poorly understood. We aimed at evaluating maternal 
anti-oxidant capacity (ceruloplasmin level, myeloperoxidase and catalase activity) in pregnancies complicated by NTDs. 
Material and methods: Fifty-four mothers with NTD-affected pregnancies and 61 healthy mothers, matched for gestational 
age, were recruited. Maternal venous blood samples were obtained after detailed fetal ultrasound examination to measure 
myeloperoxidase, catalase activity and ceruloplasmin levels. The clinical characteristics of all participants were collected. 
Results: Maternal blood catalase activity was significantly lower in the study group (117.1 ± 64.8 kU/L) as compared to 
controls (152.2 ± 110.6 kU/L) (p = 0.044). Maternal blood ceruloplasmin levels were also significantly lower in the study 
group (180.5 ± 37.7 U/L) as compared to controls (197.9 ± 35.9 U/L) (p = 0.012). Myeloperoxidase activity was similar in 
both groups (112.6 ± 22.2 U/L vs. 113.6 ± 38.1 U/L) (p = 0.869). 
Conclusions: In the present study, maternal blood ceruloplasmin level and catalase activity were found to be lower in NTD-af-
fected pregnancies as compared to healthy controls. Thus, it seems safe to conclude that impaired antioxidant capacity may 
play a role in the development of NTDs during pregnancy, in addition to the genetic, environmental and metabolic factors.
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INTRODUCTION
Neural tube defects (NTDs) are a group of heterogene-
ous and complex central nervous system disorders, affecting 
approximately 0.5–2/1000 pregnancies [1], and contributing 
to significant fetal-neonatal morbidity and mortality. Most 
NTDs result from the primary failure of the embryonic neural 
tube closure during early embryogenesis. The well-known 
mechanisms for the development of NTDs include folate 
deficiency, in utero drug exposure, and genetic susceptibil-
ity [2]. However, the exact pathogenesis of NTDs remains to 
be fully elucidated [3]. It has been reported that the direct 
relationship between antiepileptic drug therapy and the 
development of NTD is attributed to the formation of toxic 
drug metabolites and free radical damage [4]. 
Oxidative metabolism was reported to be related with 
congenital anomalies, including NTDs [3]. Free radicals or 
reactive oxygen species are generated during aerobic respi-
ration and metabolism. As a response, antioxidant defense 
mechanisms — including enzymes and chemicals which 
prevent free radical-induced damages to lipids, proteins and 
DNA — are produced by the human cells [5]. Ceruloplasmin 
is an acute-phase response protein which transports copper 
to the tissue sites and acts as an antioxidant which functions 
as an extracellular scavenger of free radicals and superoxide 
ions [6]. Free radicals play a significant role in the develop-
ment of meningomyelocele (MM), and there is a direct rela-
tionship between antioxidant enzymes, including catalase 
(CAT) and myeloperoxidase (MPO), and the development 
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of NTD [7]. CAT is an intracellular antioxidant enzyme and 
its production increases during oxidative stress in order to 
balance redox reactions [5]. MPO is another intracellular an-
tioxidant enzyme which is stored in neutrophil granules. An 
increase in the production of free radicals or reduction in 
these antioxidant systems will result in oxidative stress, 
which is found to be related to numerous disorders, includ-
ing inflammation, infection, diabetes, cancer, and cardiovas-
cular disease. Recent reports have associated oxidative stress 
with congenital anomalies, including NTDs [3, 8]. 
OBJECTIVES
In this study, maternal blood ceruloplasmin level, cata-
lase and MPO activities in pregnancies complicated by NTDs 
were investigated and compared to pregnant women with 
healthy fetuses. 
MATERIAL AND METHODS
The present study was conducted at Yuzuncu Yıl Uni-
versity Medical Faculty, Department of Obstetrics and Gy-
necology, between January 2015 and July 2015. Local Ethics 
Committee approved of the study and informed consent 
was obtained from all participants. The principles of the 
Declaration of Helsinki were followed. The study population 
included 122 pregnant women, aged 18–45 years, who were 
investigated at our referral obstetric center. All subjects were 
followed-up until delivery. NTDs were not linked to genetic 
syndromes, amniotic band disruption sequence, or ane-
uploidies. Healthy pregnant women had no earlier history of 
congenital malformations. During the postnatal period, the 
diagnosis of NTDs was made by a pediatrician and further 
confirmed by a neurosurgeon. The exclusion criteria were as 
follows: fetal anomalies outside the central nervous system, 
e.g. esophageal atresia, congenital heart or renal disease; 
multiple pregnancy, chronic maternal disease, e.g. heart 
disease or diabetes, and alcohol or smoke addiction, delivery 
in the study group and lack of NTDs confirmation during 
the postnatal period. All in all, 54 pregnant women affected 
by NTDs who fulfilled the inclusion criteria comprised the 
study group. Seven pregnant women with additional fetal 
congenital anomalies were excluded. The control group 
consisted of pregnant women, matched for gestational age, 
who were referred to our clinic for detailed fetal ultrasound 
examination and diagnosed with a healthy fetus. After de-
tailed ultrasound examination, maternal serum samples 
were obtained and stored until assayed. 
The study group included 54 mothers with NTD-affected 
pregnancies and the control group consisted of 61 moth-
ers with healthy pregnancies, matched for gestational age. 
The NTD group comprised of 18 fetuses with anencephaly 
(18/54, 33.3%), 9 with thoracolumbar spina bifida (9/54, 
16.7%), 20 with lumbosacral spina bifida (20/54, 37%), 
and  7 with encephalocele (7/54, 13%). Patient character-
istics (maternal age, gravidity, parity, BMI and gestational 
age at sampling) were recorded. 
Fasting venous blood samples were drawn after di-
agnostic ultrasonography examination to evaluate MPO, 
ceruloplasmin and catalase levels. Blood samples were cen-
trifuged quickly, sera were separated after centrifugation 
at 1500 rpm for 10 min, and stored at –80°C until delivery. 
Catalase activity was measured using the Goth’s meth-
od [9]. The sample (0.2 mL) was incubated in 1.0 mL sub-
strate (65 mmol per H2O2 in 60 mmol/L sodium–potassium 
phosphate buffer, pH 7.4) at 37°C for 60 s. The enzymatic 
reaction was stopped with 1.0 mL of 32.4 Mm ammonium 
molybdate, and the yellow complex of molybdate and 
H2O2 was measured at 405 nm against a blank. One unit 
of catalase decomposes 1 μmol of H2O2 min
–1 under these 
conditions. The results were expressed as kU/L. Serum MPO 
activity was measured by modification of the o-Dianisidine 
method [10] based on kinetic measurement at 460 nm, with 
the rate of the yellowish orange product formation from 
the oxidation of o-Dianisidine with MPO in the presence of 
hydrogen peroxide (H2O2). One unit of MPO was defined as 
that degrading 1 μmol of H2O2 min-1 at 25°C. MPO activity 
was expressed in units per liter serum. Ceruloplasmin levels 
were measured by the method described by Erel [11]. This 
method is automated, colorimetric, and based on the enzy-
matic oxidation of ferrous ion to ferric ion. The results were 
expressed in units per liter serum. 
Descriptive statistics for continuous variables (character-
istics) were presented as mean and standard deviation. Stu-
dent’s t-test was used to compare the continuous variables 
between the control and study groups. PASTE programs 
were used to analyze the data. Statistical significance level 
was considered as 5%. SPSS (IBM Corp. Released 2013. IBM 
SPSS Statistics for Windows, Version 22.0. Armonk, NY) was 
used for all statistical computations.
RESULTS
A total of 115 pregnant women were included, divided 
into two groups: 54 mothers with NTD-affected pregnancies 
(study group) and 61 healthy, matched for gestational age, 
mothers (control group). The clinical and laboratory charac-
teristics of both groups were presented in Table 1. Mean ma-
ternal age was 27.4 ± 5.8 years in the study population 
and did not differ between the study and control groups 
(p = 0.691). Mean gestational age was 20.8 ± 4.8 weeks in 
the study population. Mean gestational age at sampling did 
not differ between the study and control groups (p = 0.897). 
No significant differences between the groups in terms of 
gravidity, parity and BMI were observed. 
Maternal blood catalase activity was significantly lower 
in the study group (117.1 ± 64.8 kU/L) as compared to con-
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trols (152.2 ± 110.6 kU/L) (p = 0.044) (Fig. 1). Maternal blood 
ceruloplasmin levels were also significantly lower in the 
study group (180.5 ± 37.7 U/L) as compared to controls 
(197.9 ± 35.9 U/L) (p = 0.012) (Fig. 2). MPO activity was 
similar in both groups (112.6 ± 22.2 U/L vs. 113.6 ± 38.1 U/L) 
(p = 0.869). Figure 3 demonstrated the scatter chart of ceru-
loplasmin, catalase and MPO levels in the study and control 
groups. 
DISCUSSION
In the present study, maternal blood levels of ceruloplas-
min and catalase activity were found to be lower in pregnant 
women with NTD-complicated pregnancies as compared to 
healthy controls. However, MPO activity was similar in both 
groups. Although the exact etiology of the development of 
NTDs remains unknown, the neural tube closure during early 
embryogenesis can be affected by several factors, including 
metabolic, genetic and environmental conditions. Several 
studies have demonstrated a relationship between free 
oxygen species and NTDs [12, 13]. The well-established data 
on free-radical mediated cellular damage comes from the 
Table 1. The baseline clinical characteristics of the participants 
Controls (n = 61) Cases (n = 54) p*
Maternal age (years) 27.2 ± 5.5 27.6 ± 6.2 0.691
Gravidity 2.6 ± 1.5 2.9 ± 2.0 0.330
Parity 1.4 ± 1.4 1.7 ± 1.8 0.368
BMI [kg/m2] 25.7 ± 3.6 25.5 ± 3.0 0.801
Gestational age at sampling (weeks) 20.8 ± 2.4 20.9 ± 6.6 0.897
Catalase [kU/L] 152.2 ± 110.6 117.1 ± 64.8 0.044
Ceruloplasmin [U/L] 197.9 ± 35.9 180.5 ± 37.7 0.012
MPO [U/L] 113.6 ± 38.1 112.6 ± 22.2 0.869
*Students T-test was used for continuous variables 
Cases — mothers with neural tube defect-affected pregnancies; controls — healthy mothers with unaffected pregnancies; BMI — body mass index;  
MPO — myeloperoxidase
Figure 1. Maternal blood catalase levels of the study and control 
groups
600
500
400
300
200
100
0
Ca
ta
la
se
 [k
U
/L
]
Controls Cases
Groups
300
250
200
150
100
Ce
ru
lo
pl
as
m
in
 [u
/L
]
Controls Cases
Groups
Figure 2. Maternal blood ceruloplasmin levels of the study and 
control groups
Figure 3. The scatter chart of catalase, MPO activity and 
ceruloplasmin levels between the study and control groups
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use of antiepileptic drug complicated with NTDs [7]. In their 
experimental rat study, Ishibasia et al. showed that exposure 
to high oxygen concentration during early neurulation, ag-
gravating oxidative stress in the embryo, leads to an increase 
in NTD incidence [14]. 
Reactive oxygen species (ROS) production is a natural 
process in the body and, given the idea that increased levels 
of ROS can cause damage to both, the human body and the 
developing fetus in utero [5], the body produces a variety 
of enzymatic and non-enzymatic mechanisms to protect 
the cells against oxidative stress. These include catalase, 
superoxide dismutase, MPO, glutathione peroxidase, fer-
ritin and also ceruloplasmin, which act as antioxidants by 
removing iron which induces the oxidative reactions. It 
has been reported that impaired responsiveness of these 
antioxidant enzymes to free radicals and oxidative stress 
plays a significant role in the oxygen-induced embryopathy 
and might result in NTDs [15]. Catalase and MPO are known 
as intracellular antioxidant enzymes and catalase is found 
primarily in peroxisomes; it catalyzes a reaction between 
two H2O2 molecules, resulting in the formation of water 
and O2. In addition, catalase can promote the interaction of 
H2O2 with hydrogen donors so that H2O2 can be converted 
to one molecule of water, and the reduced donor becomes 
oxidized (peroxidatic activity of catalase) [9]. Also, cerulo-
plasmin acts as a potent antioxidant molecule by means of 
the oxidation of aromatic amines [8]. 
To date, there is only a limited number of studies which 
evaluate the oxidative status of pregnancies complicated 
with NTDs. Yazıcıoğlu et al. studied maternal blood of second 
trimester fetuses, with and without NTDs, and reported that 
ceruloplasmin levels of maternal blood were not differ-
ent in the two groups. They concluded that maybe other 
antioxidants, but not ceruloplasmin, play a role in NTD de-
velopment [6]. In contrast to that study, we added catalase 
and MPO as antioxidants, besides ceruloplasmin level, and 
found that catalase and ceruloplasmin were significantly 
lower in pregnancies complicated by NTD. On the other 
hand, Arslan et al. studied the role of erythrocyte free radical 
scavenging enzyme activities (FRSE), carbonic anhydrase 
(CA) activity and malondialdehyde (MDA) in infants with MM 
and their mothers, but not during pregnancy, and reported 
that FRSE activities were lower in all infants with MM and 
their mothers as compared to healthy infants and their 
mothers. Arslan et al. stated that lower FRSE activities may 
indicate an increased frequency of MM [16], which consist-
ent with our findings of lower catalase and ceruloplasmin 
level in pregnancies with NTD. 
Graf et al. evaluated five different antioxidant enzymes, 
including catalase, in children with MM and found signifi-
cantly lower glutathione peroxidase activities [12]. They stat-
ed that the contribution of oxidative stress to human birth 
defects warrants further investigation. However, their study 
was conducted in children with NTDs but not during the 
intrauterine period. We thought that to investigate the oxi-
dative status of these children in utero, during the develop-
mental period, would allow for a comprehensive presenta-
tion of data regarding the potential relationships between 
oxidative stress and energy metabolism during primary 
neurulation. In our study, we found lower maternal blood 
catalase activity and ceruloplasmin level at NTD diagnosis 
during pregnancy as compared to healthy pregnant women. 
It may show somehow a proof of inadequate antioxidant 
mechanisms protecting from oxidative stress under some 
circumstances, especially in terms of the development of 
congenital defects.
Several limitations of the present study should be con-
sidered. First, the activity and levels of antioxidant molecules 
other than catalase, MPO and ceruloplasmin remain to be ex-
amined. Perhaps other antioxidants play a role in the devel-
opment of NTDs. Second, we did not analyze the antioxidant 
status of the pregnant women at the beginning of gestation, 
especially during the period of organogenesis. NTDs are 
very early-onset congenital anomalies; an investigation of 
the oxidative status during embryogenesis may give a more 
comprehensive data regarding the etiopathogenesis of 
this disorder. On the other hand, the main strength of our 
study is the relatively larger sample size. Also, to the best 
of our knowledge, there have been no studies on mater-
nal blood catalase, MPO activities and ceruloplasmin level 
in pregnancies complicated by NTDs. Our study has been 
the first to evaluate these antioxidants during pregnancy 
complicated by NTDs. 
CONCLUSIONS
Based on our findings, we concluded that the decreased 
catalase activity and ceruloplasmin level are associated with 
impaired antioxidant capacity, which may play a role in 
the development of NTDs in pregnancy, in addition to the 
genetic, environmental and metabolic factors. Although we 
have demonstrated slight differences in maternal cerulo-
plasmin and catalase levels between NTD-affected pregnan-
cies and healthy controls, these results could not be used 
as parameters for prenatal NTD screening. Further studies, 
with well-structured and larger populations conducted at 
the early period of embryogenesis, are needed to investigate 
the matter further.
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